For consumers
(1300 633 424)
Mon-Fri | 9am-5pm AEST
Your call will be answered by healthdirect Australia
For health professionals
Find out the active ingredient and other brand names of your medicines with the NPS Medicine Name Finder
For a medicinewise Australia
Independent. Not-for-profit. Evidence based.
Site Tools
Quick Links
Published articles funded or supported by NPSPublished articles funded or supported by NPS
These research publications are by NPS staff or have been funded or supported by NPS.
Note: The full text of some articles are only available online with a subscription.
- About NPS
- Consumers and QUM
- e-Health initiatives
- Health Professionals and QUM
- Research and evaluation method
About NPS
| Weekes LM, Mackson JM, Fitzgerald M, Phillips SR. National Prescribing Service: creating an implementation arm for national medicines policy. Br J Clin Pharmacol 2005;59:112-116. |
2005 |
Consumers and QUM
| Consumer medicine information |
|
|---|---|
| Weekes LM, Davis J, Vaughan K, Kehoe L. Medicines Information for Consumers. Australian Pharmacist. 2006;36:91-92 | 2006 |
| Medicine census |
|
|---|---|
| Morgan T, Williamson M, Pirotta M, Stewart K, Myers S, Barnes J. A national census of medicines use: a 24-hour snapshot of Australians aged 50 years and older. Medical Journal of Australia 2012; 196 (1): 50-53 |
2012 |
e-Health initiatives
| Decision support |
|
|---|---|
| Yu K, Sweidan M, Williamson M. Drug interaction alerts – necessary but need improving? Australian Pharmacist 2012; 13(1) | 2012 |
| Yu K, Sweidan M, Williamson M, Fraser A. Drug interaction alerts in software — what do general practitioners and pharmacists want?. Medical Journal of Australia 2011; 195 (11/12): 676-680 |
2011 |
| Reeve J, Sweidan M. Setting a standard for electronic prescribing systems. Australian Prescriber 2011; 34: 2-4. |
2011 |
| Robertson J, Moxey AJ, Newby DA, Gillies MB, Williamson M, Pearson SA. Electronic information and clinical decision support for prescribing: State of play in Australian general practice. Family Practice 2011;28:93-101. |
2011 |
| Sweidan M, Reeve J, Yu K. Death and morbidity from supratherapeutic dosing of colchicine (Letter). MJA 2011; 195 (9): 517 |
2011 |
| Sweidan M, Reeve J, Dartnell J, Phillps S. Improving clinical decision support tools – challenges and a way forward. Australian Family Physician. 2011; 40(8):561-561 |
2011 |
| Moxey A, Robertson J, Newby D, Hains I, Williamson M, Pearson S-A. Computerized clinical decision support for prescribing: provision does not guarantee uptake. Journal of the American Medical Informatics Association 2010;17(1):25-33. | |
| Robertson J, Walkom E, Pearson S-A, Hains I, Williamson M, Newby D. The impact of pharmacy computerised clinical decision support on prescribing, clinical and patient outcomes: a systematic review of the literature. International Journal of Pharmacy Practice 2010;18(2):69 - 87 | |
| Brien JE, Reeve J, Sweidan M, Jayasuriya P, Martin J. Drug interaction alerts in dispensing and prescribing software (letter). J Pharm Prac & Res 2009; 39(1) 81-2 | 2009 |
| Flanagan BM, Sweidan M, Reeve JF. Room for improvement in drug interaction alerts. Australian Pharmacist 2009; 28(5):435 | 2009 |
| Pearson SA, Moxey A, Robertson J, Hains I, Williamson M, Reeve J,Newby D. Do computerised clinical decision support systems for prescribing change practice? A systematic review of the literature (1990-2007). BMC Health Services Research 2009; 9:154 | |
| Sweidan M, Reeve JF, Dartnell JGA. Consider the content of drug-drug interaction alerts (letter). Arch Int Med 2009 | 2009 |
| Sweidan M, Reeve JF, Brien JE, Jayasuriya P, Martin JH, Vernon GM. Quality of drug interaction alerts in prescribing and dispensing software. MJA 2009; 190 (5): 251-254 | |
| Reeve JF. Tenni PC. Peterson GM. An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trial. British Journal of Clinical Pharmacology 2008;65(3):377-385 | |
| Sweidan M, Reeve JF. Deficiencies in drug interaction information (letter). MJA 2007; 186(9):483 | |
| Liaw S-T, Kerr S. Computer aided prescribing: Decision support needs to be evidence based (letter). BMJ 2004;328(7455):1566 |
2004 |
| Ahearn MD, Kerr SJ. General practitioners' perceptions of the pharmaceutical decision-support tools in their prescribing software. Med J Aust 2003;179:34-7. |
| e-Prescribing | |
|---|---|
| Sweidan M, Williamson M, Reeve JF, Harvey K, O’Neill JA, Schattner P, Snowdon T. Evaluation of features to support safety and quality in general practice clinical software. BMC Medical Informatics and Decision Making 2011, 11:27 |
2011 |
| Sweidan M, Williamson M, Reeve JF, Harvey K, O'Neill JA, Schattner P, Snowdon T. Identification of features of electronic prescribing systems to support quality and safety in primary care using a modified Delphi process, BMC Medical Informatics and Decision Making 2010, 10:21 |
2010 |
| Reeve JF, Mackson JM, Sweidan M, Williamson M. The effect of advertising in clinical software on general practitioners’ prescribing behaviour (letter). Med J Aust 2008; 189(2):85 |
| Other | |
|---|---|
| Lewis B, Harvey K, Dartnell J, Shepheard J. Modelling and encoding Therapeutic Guidelines: applying ICD- 10-AM and EAN codes. Health Inf Manag 2004;32:51-58. | 2004 |
Health Professionals and QUM
Health professional education and quality improvement programs (community-based)
| Antibiotics and infections | |
|---|---|
| Wutzke SE, Artist MA, Kehoe LA, Fletcher M, Mackson JM, Weekes LM. Evaluation of a national programme to reduce inappropriate use of antibiotics for upper respiratory tract infections: effects on consumer awareness, beliefs, attitudes and behaviour in Australia. Health Promotion International 2007;22(1):53–64. | |
| Patterson CA, Mackson JM, Weekes LM. Antibiotic prescribing for upper respiratory-tract infections in primary care. Commun Dis Intell 2003;27 Suppl:S39-41 |
| Cardiovascular medicines |
|
|---|---|
| Mandryk J, Wai A, Mackson JM, Patterson C, Bhasale A, Weekes LM. Evaluating the impact of educational interventions on use of antithrombotics in Australia. Pharmacoepidemiol Drug Saf 2008;17(2):160-171 | |
| O'Riordan S, Mackson J, Weekes L. Self-reported prescribing for hypertension in general practice. Journal of Clinical Pharmacy and Therapeutics 2008;33;483-488. | |
| Ostini R, Hegney D, Mackson JM, et al. Why is the use of clopidogrel increasing rapidly in Australia? An exploration of geographical location, age, sex and cardiac stenting rates as possible influences on clopidogrel use. Pharmacoepidemiol Drug Saf 2008;17(11):1077-1090 | |
| Horn FE, Mandryk JA, Mackson JM, Wutzke SE, Weekes LM, Hyndman RJ. Measurement of changes in antihypertensive drug utilisation following primary care educational interventions. Pharmacoepidemiol Drug Saf 2007;16(3):297–308. | |
| Buchan HH, Phillips SM, Weekes LM, Mackson JM, Boyden AN, Tonkin AM. Chronic heart failure: time to optimise methods of diagnosis in the community. Med J Aust 2006;184:423-4 | |
| Hood SG, Bereznicki L, Dunt D, Jackson S, Lowe A, Mackson J, Phillips S, Pirkis J and Taylor S (2006). Interventions to improve evidence-based prescribing for heart failure. (Protocol) Cochrane Database of Systematic Reviews Issue 3. Art. No.: CD006091. DOI: 10.1002/14651858.CD006091 |
| Diabetes medicines | |
|---|---|
| Gadzhanova S, Roughead EE, Loukas K, Vajda J. Improvement in metformin and insulin utilisation in the Australian veteran population associated with quality use of medicines intervention programs. Pharmacoepidemiol Drug Saf. 2011 Apr;20(4):359-65 |
2011 |
| Other | |
|---|---|
| Ostini R, Hegney D, Jackson C, Williamson M, Mackson JM, Gurman K, Hall W, Tett SE. Systematic Review of Interventions to Improve Prescribing. Annals of Pharmacotherapy 2009;43:502-513. | |
| Weekes LM, Higgins G. Pharmacy self audits: NPS update. Australian Pharmacist 2006;25:120-121 |
2006
|
Health professional education and quality improvement programs (hospital-based)
| Pulver LK, Wai A, Maxwell DJ, Robertson MB, Riddell S. Implementation and evaluation of a multisite drug usage evaluation program across Australian hospitals - a quality improvement initiative. BMC Health Services Research 2011;11:206. |
2011 |
| Community Acquired Pneumonia | |
|---|---|
| McIntosh KA, Maxwell DJ, Pulver LK,Horn F, Robertson MB, Kaye KI, Peterson GM, Dollman WB, Wai A, Tett SE. A quality improvement initiative to improve adherence to national guidelines for empiric management of community-acquired pneumonia in emergency departments. Int J Qual Health Care 2011; 23(2):142-50. |
2011 |
| Pulver LK, Tett SE, Coombes J. The Queensland experience of participation in a national drug use evaluation project, Community-acquired pneumonia – towards improving outcomes nationally(CAPTION). BMC Pulmonary Medicine 2009;9(1):38. |
2009 |
| McIntosh KA. CAPTION (Community-Acquired Pneumonia): towards improving outcomes nationally project. Fiji Med J 2005;24:31-34. | 2005 |
| McIntosh KA, Jamshidi N, Maxwell DJ, Kaye KI, Easton KL, Stanton LA, et al. Optimising community-acquired pneumonia management. Fiji Med J 2005;24:31-34. | 2005 |
| Maxwell DJ, McIntosh KA, Pulver LK, Easton KL, Kaye K, Tett S, et al. Empiric management of community-acquired pneumonia in Australian emergency departments. Med J Aust 2005;183:520-524 |
2005 |
| Maxwell DJ, Easton KA. Community-acquired pneumonia. Journal of Pharmacy Practice and Research 2004;34:212-17. | 2004 |
| Acute Coronary Syndrome | |
|---|---|
| Wai A, Pulver L, Oliver K, Thompson A. Current Discharge Management of Acute Coronary Syndromes: Baseline results from a national quality improvement initiative. Internal Medicine Journal (Published online July 2010). |
| Post Operative Pain | |
|---|---|
| Taylor D, Fen Loh S, Mulligan K, Pulver L, Tompson A, Wai A. Management of Acute Postoperative Pain in Australian Hospitals - Room for Improvement. Journal of the Australasian Association for Quality in Health Care 2010; Summer:30-36. | 2010 |
Health professionals knowledge and attitudes
| Complementary medicines |
|
|---|---|
| Pirotta M, Kotsirilos V, Brown J, Adams J, Morgan T, Williamson M. Complementary medicine in general practice: A national survey of GP attitudes and knowledge. Australian Family Physician 2010;39(12):946-950. |
2010 |
| Brown J, Roufogalis B, Williamson, M. Complementary medicines: Hospital pharmacists' attitude, knowledge and information seeking behaviour. Journal of Pharmacy Practice and Research 2009; 39(4):281-285. | 2009 |
| New drugs and new evidence |
|
|---|---|
| Tobin L, de Almedia Neto AC, Wutzke S, et al. Influences on the prescribing of new drugs. Aust Fam Physician 2008;37(1-2):78-80 |
2008 |
| Florin THJ, Kerr SJ, Mant A, Horn FE, McGeechan K, Sayer GP, et al. Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners. Med J Aust 2004;180:310-311 | |
| Kerr SJ, Mant A, Horn FE, McGeechan K, Sayer GP. Lessons from early large-scale adoption of celecoxib and rofecoxib by Australian general practitioners. Med J Aust 2003;179:403-7 |
Nurses and QUM
| Hunt S, Green G, Stuart M. Quality Use of Medicines and Nurses. Collegian 2006;12:3 | 2006 |
Online learning
| Health professional students | |
|---|---|
| Smith A, Tasioulas T, Cockayne N, Misan G, Walker G, Quick G. Construction and evaluation of a web-based interactive prescribing curriculum for senior medical students. British Journal of Clinical Pharmacology. 2006;62(6):653-9 |
2006 |
| Smith A, Tasioulas T. Education on prescribing can be improved. BMJ 2002;325(7367):776-777. | 2002 |
Research and evaluation methods
| Beilby J, Wutzke SE, Bowman J, Mackson JM, Weekes LM. Evaluation of a national quality use of medicines service in Australia: an evolving model. J Eval Clin Pract 2006;12:202-17. |
2006 |
| Mandryk JA, Mackson JM, Horn FE, Wutzke SE, Badcock C-A, Hyndman RJ, et al. Measuring change in prescription drug utilization in Australia. Pharmacoepidemiol Drug Saf 2006;15:477-484 |
2006 |
Date published: 2008-05-01 00:00:00
Reasonable care is taken to provide accurate information at the date of creation. This information is not intended as a substitute for medical advice from a qualified health professional. Health professionals should rely on their own expertise and enquiries when providing medical advice or treatment. Where permitted by law, NPS disclaims all liability (including for negligence) for any loss, damage or injury resulting from reliance on or use of this information. Read our full disclaimer.
References to brands should not be taken as an endorsement by NPS.
